These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8684503)

  • 1. [Therapeutic (im)possibilities in Raynaud's phenomenon].
    Jager J
    Ned Tijdschr Geneeskd; 1996 May; 140(19):1044. PubMed ID: 8684503
    [No Abstract]   [Full Text] [Related]  

  • 2. [Raynaud's phenomenon and systemic diseases: immunological viewpoint].
    Lantin JP; Duc J
    Rev Med Suisse Romande; 1992 May; 112(5):401-4. PubMed ID: 1604100
    [No Abstract]   [Full Text] [Related]  

  • 3. [Dysimmune rheumatism in Raynaud's syndrome (inflammatory rheumatism, Raynaud's syndrome, speckled antinuclear factors and anti-ribonucleoprotein antibody): a new syndrome?].
    Appelboom T; Kahn MF; Peltier AP; de SEZE S
    Ann Med Interne (Paris); 1974 Nov; 125(11):841-8. PubMed ID: 4218716
    [No Abstract]   [Full Text] [Related]  

  • 4. [Raynaud's phenomenon and anticentromere antibodies].
    Marquet Palomer R; Vilardell Tarrés M; Ordi Ros J
    Med Clin (Barc); 1987 Nov; 89(17):721-4. PubMed ID: 3501051
    [No Abstract]   [Full Text] [Related]  

  • 5. Raynaud's phenomenon and initially seronegative mixed connective tissue disease.
    Ellman MH; Pachman L; Medof ME
    J Rheumatol; 1981; 8(4):632-4. PubMed ID: 6975377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Raynaud's phenomenon and systemic diseases.
    Kallenberg CG
    Vasa Suppl; 1987; 18():15-20. PubMed ID: 3299813
    [No Abstract]   [Full Text] [Related]  

  • 7. [Nursing care of the patient with autoimmune disease (collagen disease); with special reference to the care of Raynaud's phenomenon].
    Tanaka Y; Imai K
    Kango Gijutsu; 1984 Jun; 30(8):1041-6. PubMed ID: 6565057
    [No Abstract]   [Full Text] [Related]  

  • 8. [Raynaud's phenomenon in systemic rheumatic diseases of the connective tissue].
    Maksimović B
    Reumatizam; 1983; 30(1-2):18-20. PubMed ID: 6867506
    [No Abstract]   [Full Text] [Related]  

  • 9. Inefficacy of diltiazem in the treatment of Raynaud's phenomenon with associated connective tissue disease: a double blind placebo controlled study.
    da Costa J; Gomes JA; Espirito Santo J; Queirós M
    J Rheumatol; 1987 Aug; 14(4):858-9. PubMed ID: 3668998
    [No Abstract]   [Full Text] [Related]  

  • 10. Identification of transition from primary Raynaud's phenomenon to secondary Raynaud's phenomenon by nailfold videocapillaroscopy: comment on the article by Hirschl et al.
    Cutolo M; Pizzorni C; Sulli A
    Arthritis Rheum; 2007 Jun; 56(6):2102-3; author reply 2103-4. PubMed ID: 17530659
    [No Abstract]   [Full Text] [Related]  

  • 11. Electroencephalographic alterations in Raynaud's phenomenon.
    Delamonica EA; Velayos E; Shulman L
    Dis Nerv Syst; 1968 Nov; 29(11):748-53. PubMed ID: 5717290
    [No Abstract]   [Full Text] [Related]  

  • 12. [A case of overlap syndrome with idiopathic, lactic acidosis and marked hypertension preceded by frequent Raynaud's phenomenon (author's transl)].
    Kobayashi H; Arikawa K; Tsugu T; Ichikawa Y; Homma M
    Nihon Naika Gakkai Zasshi; 1981 Apr; 70(4):586-90. PubMed ID: 7288242
    [No Abstract]   [Full Text] [Related]  

  • 13. [Sympathectomy in treating Raynaud's disease in patients with collagenosis].
    Iudanova LS
    Sov Med; 1971; 34(8):138-40. PubMed ID: 5119640
    [No Abstract]   [Full Text] [Related]  

  • 14. Raynaud's phenomenon possibly induced by a compund drug of tegafur and uracil.
    Seishima M; Izumi T; Kanoh H
    Eur J Dermatol; 2000; 10(1):55-8. PubMed ID: 10694301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subclinical manifestations of autoimmune rheumatic diseases in primary Raynaud's phenomenon.
    Tzioufas AG; Dalavanga YA; Constantopoulos SH; Tsianos EB; Papadimitriou C; Moutsopoulos HM
    Clin Exp Rheumatol; 1985; 3(3):243-7. PubMed ID: 3876901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Collagenoses and Raynaud's phenomenon].
    Guillaume JC; Touraine R
    Rev Prat; 1981 Dec; 31(55):4027-8 passim. PubMed ID: 7313482
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of endothelin-1 and selected cytokines in the pathogenesis of Raynaud's phenomenon associated with systemic connective tissue diseases.
    Rychlik-Golema W; Mastej K; Adamiec R
    Int Angiol; 2006 Jun; 25(2):221-7. PubMed ID: 16763543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of antibodies to ribonucleoprotein.
    Cohen ML; Dawkins B; Dawkins RL; Owen ET
    Ann Rheum Dis; 1979 Feb; 38(1):74-8. PubMed ID: 312058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lupus erythematosus with muscular involvement and Raynaud's syndrome].
    Gajkowski K
    Neurol Neurochir Pol; 1974; 8(1):109-12. PubMed ID: 4135376
    [No Abstract]   [Full Text] [Related]  

  • 20. Raynaud's phenomenon and celiac disease.
    Gabrielli M; Candelli M; Santarelli L; Nista EC; Santoliquido A; Gasbarrini G; Pola P; Gasbarrini A
    Am J Gastroenterol; 2003 Nov; 98(11):2578-9. PubMed ID: 14638377
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.